By harnessing biology and de novo design, IMNEWRUN develops precision-engineered antibodies that cross the blood-brain barrier and unlock new possibilities in brain disease treatment.
2026
Republic of Korea, Suwon
TRANSMAB
Leadership
Driven by Science
Defined by Purpose

Core Values











